Publicacións en colaboración con investigadores/as de Aix-Marseille University (26)

2024

  1. Mortality burden and economic loss attributable to cold and heat in Central and South America

    Environmental Epidemiology, Vol. 8, Núm. 6, pp. e335

2023

  1. The submucosal approach influences long-term outcomes of refractory obstructive rhinitis: A prospective study and a STROBE analysis

    American Journal of Otolaryngology - Head and Neck Medicine and Surgery, Vol. 44, Núm. 3

2022

  1. Features of Mild-to-Moderate COVID-19 Patients With Dysphonia

    Journal of Voice, Vol. 36, Núm. 2, pp. 249-255

  2. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  3. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. Consensus on diagnosis and management of Cushing's disease: a guideline update

    The lancet. Diabetes & endocrinology, Vol. 9, Núm. 12, pp. 847-875

  2. European guideline on igg4-related digestive disease — ueg and sgf evidence-based recommendations

    Russian Journal of Gastroenterology, Hepatology, Coloproctology, Vol. 31, Núm. 1, pp. 80-114

  3. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    The Lancet Respiratory Medicine, Vol. 9, Núm. 3, pp. 260-274

  4. Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?

    Journal of the Endocrine Society, Vol. 5, Núm. 3

  5. The YO-IFOS key points to write a good paper in otolaryngology

    European Annals of Otorhinolaryngology, Head and Neck Diseases, Vol. 138, pp. 2-5

  6. The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

    Genetics in Medicine, Vol. 23, Núm. 9, pp. 1726-1737

2020

  1. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019

    Journal of Internal Medicine, Vol. 288, Núm. 3, pp. 335-344

  2. Corrigendum to “Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis” (Pancreatology (2018) 18(8) (847–854), (S1424390318306938), (10.1016/j.pan.2018.09.016))

    Pancreatology

  3. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

    European Archives of Oto-Rhino-Laryngology, Vol. 277, Núm. 8, pp. 2251-2261

2019

  1. Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

    Nature Communications, Vol. 10, Núm. 1

  2. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis

    Journal of the National Cancer Institute, Vol. 110, Núm. 6, pp. 560-567

2017

  1. A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway

    Surgical Infections, Vol. 18, Núm. 8, pp. 846-853

  2. Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15

    Journal of Neuroinflammation, Vol. 14, Núm. 1

  3. Erratum: Antimicrobials: A global alliance for optimizing their rational use in intra-abdominal infections (AGORA). [World J Emerg Surg. 11, (2016) (33)] DOI: 10.1186/s13017-016-0089-y

    World Journal of Emergency Surgery